Compare VNDA & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNDA | GENC |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.0M | 232.2M |
| IPO Year | 2005 | 1995 |
| Metric | VNDA | GENC |
|---|---|---|
| Price | $8.59 | $14.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $14.90 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 3.4M | 25.3K |
| Earning Date | 05-06-2026 | 02-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.08 |
| EPS | N/A | ★ 0.23 |
| Revenue | ★ $216,105,000.00 | $48,943,000.00 |
| Revenue This Year | $21.50 | $6.36 |
| Revenue Next Year | $38.67 | $8.32 |
| P/E Ratio | ★ N/A | $61.43 |
| Revenue Growth | ★ 8.72 | N/A |
| 52 Week Low | $3.81 | $10.80 |
| 52 Week High | $9.91 | $17.40 |
| Indicator | VNDA | GENC |
|---|---|---|
| Relative Strength Index (RSI) | 53.74 | 45.39 |
| Support Level | $7.39 | $13.56 |
| Resistance Level | $9.53 | $14.68 |
| Average True Range (ATR) | 0.51 | 0.54 |
| MACD | -0.02 | -0.19 |
| Stochastic Oscillator | 39.14 | 28.89 |
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.